Tags : Positive Decision

OxThera’s Oxabact Receives EMA’s Positive Decision on Pediatric Investigational Plan

Shots: The approval of the Pediatric Investigational Plan (PIP) is based on PDCO’s positive opinion for Oxabact (Oxalobacter formigenes) to treat pediatric patients with primary hyperoxaluria Oxabact is currently evaluated in an ongoing P-III PBO controlled clinical study across sites the US and Europe, monitoring the change in plasma oxalate and estimated glomerular filtration rate […]Read More